Collaborations in Rheumatology: A Conversation With Gastroenterology

Save

Listen as rheumatologist Dr. Kathryn Dao and gastroenterologist Dr. Amar Naik share similarities and differences in their clinical perspectives, including a conversation on some of the benefits and risks of a JAKi in each patient population.

Psoriasis for Rheumatologists

Save

Watch rheumatologist and dermatologist Dr. Saakshi Khattri and rheumatologist Dr. Shikha Singla discuss what rheumatologists can learn from psoriasis trials when making clinical decisions about psoriatic arthritis.

Diagnosis of PMR

Save

Nine perspectives now available: Red Flags in the Diagnosis of PMR; Epidemiology of PMR; Role of the PCP in Diagnosis and Care; Importance of Diagnostic Imaging; ESR/CRP in PMR; PMR Must Rule Outs; Which PMR Patients Should Rheumatologists See?; Is There Hidden GCA?; and PMR Mimics.

Hard Decisions in RA

Save

Eight debates and perspectives on Hard Decisions in RA now available.

When do you consider switching vs cycling in patients with RA after first TNFi failure?

Save

Watch rheumatologists Dr. Roy Fleischmann and Dr. Janet Pope discuss treatment options for patients with RA who have failed a TNFi. The experts consider switching to an alternate MOA vs cycling to another TNFi.

Composite Measure to Inform Management of Bio-naïve Patients with Psoriatic Arthritis

Save

Listen as rheumatologists Dr. Philip Mease and Dr. Saakshi Khattri share their insights on using composite measures to manage patients with psoriatic arthritis. In this podcast, they discuss four composite measures used in trials of an IL-23 inhibitor.

Mechanism of Action of an Interleukin (IL)–23 Inhibitor Monoclonal Antibody in Moderate to Severe Plaque Psoriasis and Active Psoriatic Arthritis

Save

This disease education update from Janssen provides an overview of an interleukin (IL)-23 inhibitor.

Disease Modification in Lupus and Lupus Nephritis: Modifying the Natural Course of the Disease

Save

Discover how you can apply the concept of disease modification in lupus and lupus nephritis to help treat patients in your clinical practice. View our infographic and walk through an interactive patient journey towards disease modification. Also, listen to leading expert Dr. Michelle Petri to learn about scientific advances in monitoring for renal damage accrual in lupus nephritis.

Heart to Heart: Experts Discuss Cardiovascular Risk in Rheumatoid Arthritis

Save

Tune in as rheumatologists Dr. Christina Charles-Schoeman and Dr. Roy Fleischmann discuss how you can help mitigate cardiovascular risk in your patients with rheumatoid arthritis.

Women in Rheumatology: Gender Issues in Disease and Management

Save

Nine videos discussing gender differences in axSpA, PsA, Vasculitis, Lung Disease, Osteoporosis, Disparities in Healthcare, and Rheumatologic Activity and Treatment, are now available.

Biologics in Lupus - Why, Who and When?

Save

Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.

A Rheum & Derm Perspective on Treating PsA and Moderate-to-Severe PsO

Save

Dr. Mease and Dr. Armstrong discuss a multidisciplinary approach and important considerations when treating patients with joint and skin concerns. Ages 18+; for HCPs only.